Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$210.38NASDAQ Closing Price as of 3:59PM ET 3/01/21

Today's Change-2.17(1.02%)
Bid (Size)$210.50 (20)
Ask (Size)$211.00 (7)
Day Low / High$209.38 - 213.69
Volume1.8 M
 

View Biotechnology IndustryPeer Comparison as of 03/01/2021

 

Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $210.38
Change: -2.17 (1.02%)
Volume: 1.8 M
3:59PM ET 3/01/2021
 
 

Moderna Inc ( NASDAQ )

Price: $157.40
Change: +2.59 (1.67%)
Volume: 15.4 M
3:59PM ET 3/01/2021
 
 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $463.05
Change: +12.48 (2.77%)
Volume: 856.8 K
4:00PM ET 3/01/2021
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Illumina Inc ( NASDAQ )

Price: $446.50
Change: +7.09 (1.61%)
Volume: 865.5 K
4:00PM ET 3/01/2021
 

Read more news Recent News

Significant Insider Sales in Shares of Vertex Pharmaceuticals (VRTX) Extends the Selling Trend of Last Quarter
10:20PM ET 3/01/2021 MT Newswires

Five insiders -- Sachdev, Silva, Dr Altshuler, Arbuckle, and Parini -- today, sold 25,896 shares of Vertex Pharmaceuticals having a market value of...

Vertex Pharmaceuticals (VRTX) Insiders Make Significant Share Sales Extending the Trend of Last Quarter
8:56PM ET 2/27/2021 MT Newswires

Five insiders -- Sachdev, Silva, Dr Altshuler, Arbuckle, and Parini -- today, disposed of 25,896 shares of Vertex Pharmaceuticals having a market value of...

--Analyst Actions: Baird Upgrades Vertex Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $252 From $220
7:38AM ET 2/23/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Significant Insider Sales in Shares of Vertex Pharmaceuticals (VRTX) Extends the Selling Trend of Last Quarter
10:20PM ET 2/22/2021 MT Newswires

SEC filings today reported notable insider sales of Vertex Pharmaceuticals shares as five insiders -- Sachdev, Silva, Dr Altshuler, Arbuckle, and Parini --...

Company Profile

Business DescriptionVertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. View company web site for more details
Address50 Northern Avenue
Boston, Massachusetts 02210
Phone+1.617.341.6100
Number of Employees2,500
Recent SEC Filing02/26/20214
President, Chief Executive Officer & DirectorReshma Kewalramani
Chief Financial Officer & Executive Vice PresidentCharles F. Wagner
Chief Scientific Officer & EVP-Global ResearchDavid Matthew Altshuler
Senior VP, Chief Information & Data OfficerMike Tirozzi

Company Highlights

Price Open$212.68
Previous Close$212.55
52 Week Range$197.47 - 306.08
Market Capitalization$54.7 B
Shares Outstanding260.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement05/05/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings20.64
Earnings per Share$9.81
Beta vs. S&P 500N/A
Revenue$3.0 B
Net Profit Margin43.67%
Return on Equity35.21%

Analyst Ratings as of 02/27/2021

Buy
20
Overweight
4
Hold
4
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset